Paulene Mclean Quigley Sheldon

Title: Paulene Mclean Quigley Sheldon: Innovator in Gene Therapy

Introduction

Paulene Mclean Quigley Sheldon is a notable inventor based in Seattle, WA (US). She has made significant contributions to the field of gene therapy through her innovative work on recombinant adeno-associated virus (rAAV) vectors. With a total of 2 patents, her research has the potential to impact medical treatments and vaccination strategies.

Latest Patents

Her latest patents focus on methods for the purification of recombinant AAV vectors. These methods are designed to enhance gene transfer capabilities, specifically for applications in gene therapy and vaccination. The recombinant AAV vectors developed through her work are substantially free of in-process impurities, including cellular nucleic acids, cellular proteins, helper virus, and media components. This purification process is crucial for ensuring the safety and efficacy of gene therapies.

Career Highlights

Paulene is currently associated with Genzyme Corporation, where she continues to advance her research in gene therapy. Her work has garnered attention for its innovative approach to addressing challenges in the purification of viral vectors used in therapeutic applications.

Collaborations

Throughout her career, Paulene has collaborated with esteemed colleagues, including Peter S Gagnon and Barbara A Thorne. These collaborations have further enriched her research and contributed to the development of effective gene therapy solutions.

Conclusion

Paulene Mclean Quigley Sheldon stands out as a pioneering inventor in the field of gene therapy. Her contributions through innovative purification methods for recombinant AAV vectors are poised to make a significant impact on future medical treatments.